Llwytho...

Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease

Alzheimer’s disease (AD) is the most common cause of dementia among older people. There are no effective medications currently available to prevent and treat AD and halt disease progression. Monoacylglycerol lipase (MAGL) is the primary enzyme metabolizing the endocannabinoid 2-arachidonoylglycerol...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Chen, Rongqing, Zhang, Jian, Wu, Yan, Wang, Dongqing, Feng, Guoping, Tang, Ya-Ping, Teng, Zhaoqian, Chen, Chu
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513645/
https://ncbi.nlm.nih.gov/pubmed/23122958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2012.09.030
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!